| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10637-008-9126-3 |
| P698 | PubMed publication ID | 18368291 |
| P2093 | author name string | Young-Hyuck Im | |
| Keunchil Park | |||
| Myung-Ju Ahn | |||
| Won Ki Kang | |||
| Jin Seok Ahn | |||
| Ho-Yeong Lim | |||
| Sang Cheol Lee | |||
| Byeong-Bae Park | |||
| In Gyu Hwang | |||
| P2860 | cites work | Molecular precursor lesions in oesophageal cancer | Q33734022 |
| Chemotherapy in esophageal cancer. | Q33776319 | ||
| Esophageal cancer: chemotherapy as palliative therapy | Q35914817 | ||
| Phase II study of gemcitabine and cisplatin in locally advanced/metastatic oesophageal cancer | Q36614893 | ||
| Capecitabine plus docetaxel every 3 weeks in first- and second-line metastatic oesophageal cancer: final results of a phase II trial | Q36616002 | ||
| Phase II trial of irinotecan plus docetaxel in cisplatin-pretreated relapsed or refractory oesophageal cancer | Q36648325 | ||
| Chemotherapy and combined-modality therapy for esophageal cancer | Q40544941 | ||
| Phase II trial of vinorelbine in metastatic squamous cell esophageal carcinoma. European Organization for Research and Treatment of Cancer Gastrointestinal Treat Cancer Cooperative Group | Q42557591 | ||
| Phase II evaluation of protracted infusion of cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG) Trial (JCOG9407). | Q43786842 | ||
| Phase II trial of docetaxel chemotherapy in patients with incurable adenocarcinoma of the esophagus | Q43988072 | ||
| Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life | Q44545383 | ||
| Preoperative mitomycin, ifosfamide, and cisplatin followed by esophagectomy in squamous cell carcinoma of the esophagus: pathologic complete response induced by chemotherapy leads to long-term survival. | Q44633990 | ||
| Phase II study of irinotecan and 5-fluorouracil/leucovorin in patients with primary refractory or relapsed advanced oesophageal and gastric carcinoma | Q44695858 | ||
| Gemcitabine and cisplatin for patients with metastatic or recurrent esophageal carcinoma: a Southwest Oncology Group Study | Q44715314 | ||
| A phase II study of single-agent docetaxel in patients with metastatic esophageal cancer | Q44902236 | ||
| Cisplatin and 5-fluorouracil in the primary management of squamous esophageal cancer | Q44981923 | ||
| A phase II trial of gemcitabine, 5-fluorouracil and leucovorin in advanced esophageal carcinoma | Q46666199 | ||
| Esophageal Cancer | Q56209683 | ||
| Phase II evaluation of cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the esophagus: a Japanese Esophageal Oncology Group Trial | Q68034922 | ||
| Preoperative chemotherapy, surgical resection, and selective postoperative therapy for squamous cell carcinoma of the esophagus | Q68306883 | ||
| A phase II study of mitomycin, ifosfamide and cisplatin in operable and inoperable squamous cell carcinoma of the oesophagus | Q72031557 | ||
| P433 | issue | 4 | |
| P921 | main subject | ifosfamide | Q418560 |
| esophageal squamous cell carcinoma | Q108442577 | ||
| P304 | page(s) | 387-392 | |
| P577 | publication date | 2008-03-27 | |
| P1433 | published in | Investigational New Drugs | Q2312231 |
| P1476 | title | Salvage chemotherapy with mitomycin C, ifosfamide, and cisplatin (MIC) for previously treated metastatic or recurrent esophageal squamous cell carcinoma | |
| P478 | volume | 26 |
| Q33591847 | A multicenter phase II study of salvage photodynamic therapy using talaporfin sodium (ME2906) and a diode laser (PNL6405EPG) for local failure after chemoradiotherapy or radiotherapy for esophageal cancer |
| Q91789465 | Association Between Multiple Lines of Active Therapy and Prognosis in Esophageal Squamous Cell Carcinoma |
| Q39015925 | Featured article: autophagic activation with nimotuzumab enhanced chemosensitivity and radiosensitivity of esophageal squamous cell carcinoma |
| Q37368954 | Identification of exon 19 and 21 mutations of EGFR gene in Chinese patients with esophageal squamous cell carcinoma |
| Q36996728 | New and emerging combination therapies for esophageal cancer |
| Q38892190 | Personalized and targeted therapy of esophageal squamous cell carcinoma: an update |
| Q34348291 | Phase I study of photodynamic therapy using talaporfin sodium and diode laser for local failure after chemoradiotherapy for esophageal cancer |
| Q34056960 | Photodynamic therapy as salvage treatment for local failure after chemoradiotherapy in patients with esophageal squamous cell carcinoma: a phase II study. |
| Q36475391 | Role of epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of esophageal carcinoma and the suggested mechanisms of action |
Search more.